Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05256069 · ClinicalTrials.gov registry record · Early Phase 1
Sex-related Differences in Sympathetic Vascular Transduction in the Setting of Hypoxemia
A Early Phase 1 study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 31
- Enrollment target
NCT05256069: Completed Early Phase 1 study, sponsored by University of Missouri-Columbia.
NCT05256069 is a Early Phase 1 study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 31 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05256069, a Early Phase 1 study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this project is to identify sex-related differences in the effect of hypoxia on sympathetic vascular transduction.
Primary Outcome
Measured with venous occlusion plethysmography (mL/dL/min)
Interventions
- DRUG Placebo
- DRUG Propranolol Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2023-04-26 |
| Est. Completion | 2025-07-31 |
| Phase | Early Phase 1 |
What the finished NCT05256069 record still lists
NCT05256069 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (42% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05256069 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05256069 about?
NCT05256069 is a clinical study titled "Sex-related Differences in Sympathetic Vascular Transduction in the Setting of Hypoxemia". The purpose of this project is to identify sex-related differences in the effect of hypoxia on sympathetic vascular transduction.
What is the current status of trial NCT05256069?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 31 participants. The study started on 2023-04-26. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT05256069?
The interventions under investigation include: Placebo (DRUG), Propranolol Pill (DRUG).
Who is sponsoring clinical trial NCT05256069?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05256069's enrollment target sits among peer trials
31 794th of 2000 higher than 1,195 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI